Association of HLA-B alleles with human immunodeficiency virus type 1 infection in the Yi ethnic group in Sichuan Province

Biomedical and Environmental Sciences

Volumn 17, Issue 2, 2004, Pages 203-208

  Xu, Ming Yan ^a,b   Hong, Kun Xue ^a   Deng, Xiao Ling ^b   Li, Jun ^b   Peng, Hong ^a   Ruan, Yu Hua ^a   Qin, Guan Ming ^c   Xing, Hui ^a   Xu, Xiao Hu ^b   Shao, Yi Ming ^a  

^a China CDC   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c SICHUAN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Association; HIV infections; HLA B alleles

Indexed keywords

HLA B ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; ETHNOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; POLYMERASE CHAIN REACTION; SEROLOGY;

CASE-CONTROL STUDIES; CHINA; DNA; ETHNIC GROUPS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HLA-B ANTIGENS; HUMANS; POLYMERASE CHAIN REACTION; QUESTIONNAIRES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 4243078519     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. UNAIDS. (2002). AIDS epidemic update 2002. http://www.unaids.org/ epidemic_update
2. Carrington, M. and O'Brien, S. J. (2003). The influence of HLA genotype on AIDS. Annu. Rev. Med. 54, 535-551.
3. Hill, A. V., Elvin, J., Willis, A. C., Aidoo, M., Allsopp, C. E., Gotch, F. M., Gao, X. M., Takiguchi, M., Greenwood, B. M., Townsend, A. R., McMichael, A. J., and Whittle, H. C. (1992). Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360, 434-439.
4. Rohowsky-Kochan, C., Skurnick, J., Molinaro, D., and Louria, D. (1998). HLA antigens associated with susceptibility/Resistance to HIV-1 infection. Hum. Immunol. 59, 802-815.
5. Tonks, S., Marsh, S. G., Bunce, M., and Bodmer, J. G. (1999). Molecular typing for HLA class I using ARMS-PCR: further developments following the 12th International Histocompatibility Workshop. Tissue Antigens 53, 175-183.
6. Pozzi, S., Longo, A., and Ferrara, G. B. (1999). HLA-B locus sequence-based typing. Tissue Antigens 53, 275-281.
7. Woolf, B. (1955). On estimating the relation between blood group and disease. Ann. Hum. Genet. 19, 251-253.
8. Rowland-Jones, S., Tan, R., and McMichael, A. (1997). Role of cellular immunity in protection against HIV infection. Adv. Immunol. 65, 277-346.
9. Hurley, C. K., Maiers, M., Ng, J., Wagage, D., Hegland, J., Baisch, J., Endres, R., Fernandez-Vina, M., Heine, U., Hsu, S., Kamoun, M., Mitsuishi, Y., Monos, D., Noreen, H., Perlee, L., Rodriguez-Marino, S., Smith, A., Stastny, P., Trucco, M., Yang, S. Y., Yu, N., Holsten, R., Hartzman, R. J., and Setterholm, M. (2000). Large-scale DNA-based typing of HLA-A and HLA-B at low resolution is highly accurate specific and reliable. Tissue Antigens 55, 352-358.
10. Trachtenberg, E. A. and Erlich, H. A. (2001). A review of the role of the human leukocyte antigen (HLA) system as a host immunogenetic factor influencing HIV transmission and progression to AIDS. HIV Molecular Immunology Database 43-60.
11. Gao, X., Nelson, G. W., Karacki, P., Martin, M. P., Phair, J., Kaslow, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., O'Brien, S. J., and Carrington, M. (2001). Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344, 1668-1675.
12. Flores-Villanueva, P. O., Yunis, E. J., Delgado, J. C., Vittinghoff, E., Buchbinder, S., Leung, J. Y., Uglialoro, A. M., Clavijo, O. P., Rosenberg, E. S., Kalams, S. A., Braun, J. D., Boswell, S. L., Walker, B. D., and Goldfeld, A. E. (2001). Control of HIV-1 virema and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc. Natl. Acad. Sci. USA. 98, 5140-5145.
13. Carrington, M., Nelson, G. W., Martin, M. P., Kissner, T., Vlahov, D., Goedert, J. J., Kaslow, R., Buchbinder, S., Hoots, K., and O'Brien, S. J. (1999). HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage. Science 283, 1748-1752.